PANELLIST – Achieving scientific substantiation of microbiome modulators and their health effects
Dr. Christopher Martoni is Principal Scientist at UAS Labs LLC, a position he has held since 2015. His responsibilities include overseeing the clinical research and development of UAS Labs suite of probiotic strains and product offerings. Previously he was Senior Scientist at Micropharma Limited, where he was research team leader for LRC™, a probiotic developed and targeted for heart health applications. Dr. Martoni received a Ph.D. in Biomedical Engineering from McGill University in Montreal, Canada and a B.Sc. in Chemistry from the University of Virginia. He has co-authored over 40 peer-reviewed publications as well as several granted patents and applications. Throughout his career, Dr. Martoni has been the recipient of a number of academic awards and distinctions, including from the Natural Sciences and Engineering Research Council of Canada, the Health Research Fund of Quebec and McGill University.